Symbols / MDRX
MDRX Chart
About
Veradigm Inc., a healthcare technology company, provides information technology solutions to healthcare providers, payers, and biopharma markets in the United States and internationally. The company offers solutions to healthcare providers, comprising practice management software, AI patient scheduling software, and electronic statements and payments, and payerpath clearinghouse; revenue cycle services and coding services; electronic health records solutions, which include eprescribe with EPCS, EHR software, veradigm EHR, and practice fusion EHR; and patient engagement platform. It also provides solutions to network partners, which comprise API connectivity solutions, such as veradigm connect, veradigm app expo, and diagnostic ordering and resulting network; life sciences, health plans and payers, and providers; and veradigm eprescribe enterprise. In addition, the company offers risk adjustment solutions, such as health equity analytics, risk adjustment analytics, risk mitigator, comprehensive submissions, and utilization analytics; quality analytics, risk adjustment, and quality management; data exchange and coding solutions, including echart courier, echart coder, and echart integration and analytics; clinical data registries for physicians and veradigm payer insights; provider engagement solutions; care gap alerting, gap closure services, and veradigm payerpath solutions. Further, it provides real world data solutions, such as NLP-enriched EHR data solutions, and clinical data registries; real world evidence and real-world evidence analytics platform; and digital health media solutions. The company was formerly known as Allscripts Healthcare Solutions, Inc. and changed its name to Veradigm Inc. in January 2023. Veradigm Inc. was founded in 1986 and is headquartered in Chicago, Illinois.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Health Information Servi | Market Cap | 516.19M |
| Enterprise Value | 191.75M | Income | -20.04M | Sales | 588.02M |
| Book/sh | 9.59 | Cash/sh | 4.55 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2450 | IPO | — |
| P/E | — | Forward P/E | 16.93 | PEG | — |
| P/S | 0.88 | P/B | 0.49 | P/C | — |
| EV/EBITDA | 3.71 | EV/Sales | 0.33 | Quick Ratio | 2.70 |
| Current Ratio | 2.95 | Debt/Eq | 18.59 | LT Debt/Eq | — |
| EPS (ttm) | -0.18 | EPS next Y | 0.28 | EPS Growth | -1.80% |
| Revenue Growth | 5.00% | Earnings | 2025-03-17 20:00 | ROA | -0.62% |
| ROE | -1.69% | ROIC | — | Gross Margin | 52.45% |
| Oper. Margin | 16.59% | Profit Margin | -14.70% | Shs Outstand | 108.90M |
| Shs Float | 87.02M | Short Float | — | Short Ratio | 3.92 |
| Short Interest | — | 52W High | 6.00 | 52W Low | 3.00 |
| Beta | 0.55 | Avg Volume | 261.79K | Volume | 9.96K |
| Target Price | $4.75 | Recom | Hold | Prev Close | $4.60 |
| Price | $4.74 | Change | 3.04% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$4.75
Mean price target
2. Current target
$4.74
Latest analyst target
3. DCF / Fair value
$20.05
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$4.74
Low
$4.50
High
$5.00
Mean
$4.75
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-01-31 | main | Stephens & Co. | Equal-Weight → Equal-Weight | $13 |
| 2024-05-28 | main | TD Cowen | Buy → Buy | $15 |
| 2024-03-19 | down | Deutsche Bank | Buy → Hold | $10 |
| 2024-01-19 | main | RBC Capital | Outperform → Outperform | $11 |
| 2024-01-03 | init | Barclays | — → Equal-Weight | $11 |
| 2023-11-14 | reit | Stephens & Co. | Equal-Weight → Equal-Weight | $13 |
| 2023-10-10 | reit | Stephens & Co. | Equal-Weight → Equal-Weight | $13 |
| 2023-07-06 | down | Argus Research | Buy → Hold | — |
| 2023-04-12 | init | Stephens & Co. | — → Equal-Weight | $13 |
| 2023-02-01 | down | Piper Sandler | Overweight → Neutral | $19 |
| 2022-12-07 | up | Argus Research | Hold → Buy | $26 |
| 2022-11-18 | main | JP Morgan | — → Underweight | $20 |
| 2022-11-09 | up | Goldman Sachs | Neutral → Buy | $23 |
| 2022-09-16 | init | Keybanc | — → Sector Weight | — |
| 2022-07-12 | init | Goldman Sachs | — → Neutral | $21 |
| 2022-06-10 | main | Piper Sandler | — → Neutral | $17 |
| 2022-05-06 | main | Piper Sandler | — → Neutral | $19 |
| 2022-03-18 | main | Piper Sandler | — → Neutral | $22 |
| 2022-03-04 | up | Deutsche Bank | Hold → Buy | $26 |
| 2022-03-03 | main | SVB Leerink | — → Outperform | $24 |
- Veradigm (NASDAQ:MDRX) Shares Gap Up - Here's Why - MarketBeat Wed, 25 Feb 2026 18
- Veradigm Cleared as SEC Formally Closes Investigation - TipRanks ue, 24 Feb 2026 21
- Veradigm: A Relisting Special Situation With Strategic Optionality (OTCMKTS:MDRX) - Seeking Alpha Fri, 26 Sep 2025 07
- Veradigm Extends Stockholder Rights Plan - Business Wire Mon, 02 Feb 2026 08
- Veradigm Inc Exposed: Is MDRX the Sleeper Tech Stock Everyone’s Sleeping On? - AD HOC NEWS Mon, 02 Feb 2026 08
- Veradigm (NASDAQ:MDRX) Shares Up 13.5% - Should You Buy? - MarketBeat hu, 12 Feb 2026 08
- Veradigm Recognized with KLAS 2025 Points of Light Award for Opt - GuruFocus ue, 20 May 2025 07
- Veradigm Recognized with KLAS 2025 Points of Light Award for Optimizing Value-Based Care - Stock Titan ue, 20 May 2025 07
- MDRX Stock Price and Chart — OTC:MDRX - TradingView hu, 29 Feb 2024 16
- Veradigm Extends Board Observer Agreement with Charles Myers - TipRanks ue, 20 Jan 2026 08
- Veradigm (NASDAQ:MDRX) Shares Gap Up - Should You Buy? - MarketBeat Wed, 11 Feb 2026 08
- Veradigm (MDRX) to Acquire AI Service Provider ScienceIO - Nasdaq Fri, 01 Mar 2024 08
- Healthcare Practices Earn $100 Per Patient Using Veradigm's Point-of-Care Alert System - Stock Titan ue, 11 Mar 2025 07
- Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation - PR Newswire ue, 26 Mar 2024 07
- Veradigm Inc (MDRX) Announces Strategic Acquisition of ScienceIO to Enhance AI Capabilities - Yahoo Finance ue, 27 Feb 2024 08
Insider Transactions
| Date | Shares | Url | Text | Insider | Position | Transaction | Start Date | Ownership | Value |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 423998 | — | — | SYED TEHSIN M | Chief Technology Officer | — | 2025-11-03 00:00:00 | D | nan |
| 1 | 105999 | — | — | BAKER TALLY | Officer | — | 2025-11-03 00:00:00 | D | nan |
| 2 | 571428 | — | Stock Award(Grant) at price 5.25 per share. | TRIGG DONALD | Chief Executive Officer | — | 2025-09-02 00:00:00 | D | 2999997.0 |
| 3 | 46512 | — | Stock Award(Grant) at price 4.30 per share. | FELT BRUCE C. JR. | Director | — | 2025-06-02 00:00:00 | D | 200002.0 |
| 4 | 58140 | — | Stock Award(Grant) at price 4.30 per share. | HAMMOND LISA | Officer | — | 2025-06-02 00:00:00 | D | 250002.0 |
| 5 | 46512 | — | Stock Award(Grant) at price 4.30 per share. | ASAR VINIT K. | Director | — | 2025-06-02 00:00:00 | D | 200002.0 |
| 6 | 46512 | — | Stock Award(Grant) at price 4.30 per share. | STEVENS DAVID B | Director | — | 2025-06-02 00:00:00 | D | 200002.0 |
| 7 | 46512 | — | Stock Award(Grant) at price 4.30 per share. | ZIERHOFFER CAROL J | Director | — | 2025-06-02 00:00:00 | D | 200002.0 |
| 8 | 46512 | — | Stock Award(Grant) at price 4.30 per share. | RODRIGUEZ SUSAN | Director | — | 2025-06-02 00:00:00 | D | 200002.0 |
| 9 | 69768 | — | Stock Award(Grant) at price 4.30 per share. | VAKHARIA TEJAL | General Counsel | — | 2025-06-02 00:00:00 | D | 300002.0 |
Financials
| Line Item | 2022-12-31 | 2021-12-31 |
|---|---|---|
| TaxEffectOfUnusualItems | -1.87M | 15.16M |
| TaxRateForCalcs | 0.21 | 0.19 |
| NormalizedEBITDA | 67.34M | 163.62M |
| TotalUnusualItems | -8.91M | 79.79M |
| TotalUnusualItemsExcludingGoodwill | -8.91M | 79.79M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -20.04M | 127.78M |
| ReconciledDepreciation | 115.92M | 72.78M |
| ReconciledCostOfRevenue | 224.56M | 231.49M |
| EBITDA | 58.42M | 243.41M |
| EBIT | -57.50M | 170.63M |
| NetInterestIncome | -1.45M | -12.71M |
| InterestExpense | 6.35M | 12.93M |
| InterestIncome | 4.90M | 210.00K |
| NormalizedIncome | -13.00M | 63.15M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -86.46M | 139.56M |
| TotalExpenses | 607.57M | 500.13M |
| TotalOperatingIncomeAsReported | -27.10M | 76.77M |
| DilutedAverageShares | 138.70M | |
| BasicAverageShares | 130.10M | |
| DilutedEPS | 0.97 | |
| BasicEPS | 1.03 | |
| DilutedNIAvailtoComStockholders | -86.46M | 139.56M |
| NetIncomeCommonStockholders | -86.46M | 139.56M |
| NetIncome | -86.46M | 139.56M |
| MinorityInterests | 0.00 | |
| NetIncomeIncludingNoncontrollingInterests | -86.46M | 139.56M |
| NetIncomeDiscontinuousOperations | -66.42M | 11.79M |
| NetIncomeContinuousOperations | -20.04M | 127.78M |
| TaxProvision | -43.81M | 29.93M |
| PretaxIncome | -63.85M | 157.71M |
| OtherIncomeExpense | -42.84M | 93.12M |
| OtherNonOperatingIncomeExpenses | -32.79M | 11.58M |
| SpecialIncomeCharges | -15.12M | 4.33M |
| GainOnSaleOfPPE | 0.00 | 1.65M |
| GainOnSaleOfBusiness | 0.00 | 8.37M |
| WriteOff | 15.12M | 5.69M |
| ImpairmentOfCapitalAssets | 0.00 | |
| EarningsFromEquityInterest | -1.14M | 1.76M |
| GainOnSaleOfSecurity | 6.21M | 75.46M |
| NetNonOperatingInterestIncomeExpense | -1.45M | -12.71M |
| InterestExpenseNonOperating | 6.35M | 12.93M |
| InterestIncomeNonOperating | 4.90M | 210.00K |
| OperatingIncome | -19.55M | 77.30M |
| OperatingExpense | 327.97M | 205.15M |
| DepreciationAmortizationDepletionIncomeStatement | 60.88M | 9.28M |
| DepreciationAndAmortizationInIncomeStatement | 60.88M | 9.28M |
| Amortization | 60.88M | 9.28M |
| AmortizationOfIntangiblesIncomeStatement | 60.88M | 9.28M |
| ResearchAndDevelopment | 97.89M | 84.10M |
| SellingGeneralAndAdministration | 169.20M | 111.76M |
| GrossProfit | 308.42M | 282.45M |
| CostOfRevenue | 279.60M | 294.98M |
| TotalRevenue | 588.02M | 577.43M |
| OperatingRevenue | 588.02M | 577.43M |
| Line Item | 2022-12-31 | 2021-12-31 |
|---|---|---|
| TreasurySharesNumber | 173.48M | 160.59M |
| OrdinarySharesNumber | 106.07M | 116.11M |
| ShareIssued | 279.55M | 276.70M |
| NetDebt | 216.40M | |
| TotalDebt | 219.44M | 372.95M |
| TangibleBookValue | 320.46M | 631.19M |
| InvestedCapital | 1.22B | 1.71B |
| WorkingCapital | 449.33M | 160.79M |
| NetTangibleAssets | 320.46M | 631.19M |
| CapitalLeaseObligations | 19.05M | 22.89M |
| CommonStockEquity | 1.02B | 1.36B |
| TotalCapitalization | 1.22B | 1.71B |
| TotalEquityGrossMinorityInterest | 1.02B | 1.36B |
| StockholdersEquity | 1.02B | 1.36B |
| GainsLossesNotAffectingRetainedEarnings | -74.00K | -2.76M |
| TreasuryStock | 1.56B | 1.32B |
| RetainedEarnings | 645.81M | 719.79M |
| AdditionalPaidInCapital | 1.93B | 1.96B |
| CapitalStock | 2.79M | 2.77M |
| CommonStock | 2.79M | 2.77M |
| PreferredStock | 0.00 | |
| TotalLiabilitiesNetMinorityInterest | 487.22M | 950.64M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 256.90M | 462.22M |
| OtherNonCurrentLiabilities | 44.07M | 33.82M |
| LiabilitiesHeldforSaleNonCurrent | 0.00 | 42.71M |
| NonCurrentDeferredLiabilities | 0.00 | 18.87M |
| NonCurrentDeferredRevenue | 0.00 | 186.00K |
| NonCurrentDeferredTaxesLiabilities | 0.00 | 18.69M |
| LongTermDebtAndCapitalLeaseObligation | 212.84M | 366.82M |
| LongTermCapitalLeaseObligation | 12.44M | 16.75M |
| LongTermDebt | 200.40M | 350.06M |
| CurrentLiabilities | 230.31M | 488.42M |
| OtherCurrentLiabilities | 298.99M | |
| CurrentDeferredLiabilities | 90.10M | 87.89M |
| CurrentDeferredRevenue | 90.10M | 87.89M |
| CurrentDebtAndCapitalLeaseObligation | 6.61M | 6.13M |
| CurrentCapitalLeaseObligation | 6.61M | 6.13M |
| PensionandOtherPostRetirementBenefitPlansCurrent | 35.94M | 30.35M |
| PayablesAndAccruedExpenses | 97.67M | 65.07M |
| CurrentAccruedExpenses | 62.82M | 58.87M |
| Payables | 34.85M | 6.20M |
| TotalTaxPayable | 4.01M | 4.02M |
| AccountsPayable | 30.84M | 2.17M |
| TotalAssets | 1.50B | 2.31B |
| TotalNonCurrentAssets | 825.07M | 1.66B |
| OtherNonCurrentAssets | 1.16M | 826.04M |
| NonCurrentPrepaidAssets | 10.10M | 13.83M |
| NonCurrentDeferredAssets | 37.19M | 0.00 |
| NonCurrentDeferredTaxesAssets | 37.19M | 0.00 |
| NonCurrentAccountsReceivable | 56.80M | |
| InvestmentsAndAdvances | 58.13M | 56.70M |
| InvestmentinFinancialAssets | 58.13M | 56.70M |
| AvailableForSaleSecurities | 58.13M | 56.70M |
| GoodwillAndOtherIntangibleAssets | 697.05M | 729.19M |
| OtherIntangibleAssets | 164.41M | 230.83M |
| Goodwill | 532.64M | 498.36M |
| NetPPE | 21.44M | 36.06M |
| AccumulatedDepreciation | -154.64M | -210.87M |
| GrossPPE | 176.07M | 246.93M |
| Leases | 14.44M | 14.44M |
| OtherProperties | 11.98M | 18.32M |
| MachineryFurnitureEquipment | 149.66M | 214.17M |
| Properties | 0.00 | 0.00 |
| CurrentAssets | 679.65M | 649.21M |
| OtherCurrentAssets | 208.00K | 546.00K |
| AssetsHeldForSaleCurrent | 0.00 | 277.63M |
| RestrictedCash | 1.31M | 1.31M |
| PrepaidAssets | 55.82M | 51.21M |
| Receivables | 175.72M | 184.86M |
| OtherReceivables | 56.57M | 65.17M |
| TaxesReceivable | 0.00 | |
| AccountsReceivable | 119.15M | 119.70M |
| AllowanceForDoubtfulAccountsReceivable | -22.74M | -21.62M |
| GrossAccountsReceivable | 141.89M | 141.32M |
| CashCashEquivalentsAndShortTermInvestments | 446.59M | 133.66M |
| CashAndCashEquivalents | 446.59M | 133.66M |
| Line Item | 2022-12-31 | 2021-12-31 |
|---|---|---|
| FreeCashFlow | 83.30M | -118.00M |
| RepurchaseOfCapitalStock | -234.43M | -417.44M |
| RepaymentOfDebt | -200.00M | -75.00M |
| IssuanceOfDebt | 21.64M | 250.00M |
| CapitalExpenditure | -32.27M | -41.38M |
| EndCashPosition | 447.90M | 191.65M |
| BeginningCashPosition | 191.65M | 539.80M |
| EffectOfExchangeRateChanges | 452.00K | 28.00K |
| ChangesInCash | 255.80M | -348.18M |
| FinancingCashFlow | -444.91M | -258.87M |
| CashFlowFromContinuingFinancingActivities | -444.91M | -258.87M |
| NetOtherFinancingCharges | -32.13M | -16.42M |
| NetCommonStockIssuance | -234.43M | -417.44M |
| CommonStockPayments | -234.43M | -417.44M |
| NetIssuancePaymentsOfDebt | -178.36M | 175.00M |
| NetShortTermDebtIssuance | -75.00M | |
| ShortTermDebtPayments | -75.00M | |
| ShortTermDebtIssuance | 250.00M | |
| NetLongTermDebtIssuance | -178.36M | 175.00M |
| LongTermDebtPayments | -200.00M | -75.00M |
| LongTermDebtIssuance | 21.64M | 250.00M |
| InvestingCashFlow | 585.15M | -12.70M |
| CashFromDiscontinuedInvestingActivities | -13.14M | -37.70M |
| CashFlowFromContinuingInvestingActivities | 598.28M | 25.00M |
| NetInvestmentPurchaseAndSale | -9.93M | -2.42M |
| PurchaseOfInvestment | -9.93M | -2.42M |
| NetBusinessPurchaseAndSale | 640.48M | 68.81M |
| SaleOfBusiness | 672.47M | 68.81M |
| PurchaseOfBusiness | -31.99M | 0.00 |
| CapitalExpenditureReported | -32.27M | -41.38M |
| OperatingCashFlow | 115.56M | -76.62M |
| CashFromDiscontinuedOperatingActivities | -23.26M | -190.31M |
| CashFlowFromContinuingOperatingActivities | 138.82M | 113.70M |
| ChangeInWorkingCapital | 23.57M | -18.28M |
| ChangeInOtherWorkingCapital | 7.68M | -37.98M |
| ChangeInOtherCurrentLiabilities | 10.25M | 1.33M |
| ChangeInOtherCurrentAssets | -4.49M | 1.74M |
| ChangeInPayablesAndAccruedExpense | 1.36M | -15.31M |
| ChangeInAccruedExpense | -26.51M | -5.24M |
| ChangeInPayable | 27.87M | -10.07M |
| ChangeInAccountPayable | 27.87M | -10.07M |
| ChangeInPrepaidAssets | -776.00K | 32.20M |
| ChangeInReceivables | 9.55M | -257.00K |
| OtherNonCashItems | 100.28M | -88.24M |
| StockBasedCompensation | 25.12M | 11.81M |
| AssetImpairmentCharge | 15.12M | 5.69M |
| DeferredTax | -55.88M | 502.00K |
| DeferredIncomeTax | -55.88M | 502.00K |
| DepreciationAmortizationDepletion | 115.92M | 72.78M |
| DepreciationAndAmortization | 115.92M | 72.78M |
| OperatingGainsLosses | 1.14M | -10.13M |
| EarningsLossesFromEquityInvestments | 1.14M | -1.76M |
| GainLossOnSaleOfBusiness | 0.00 | -8.37M |
| NetIncomeFromContinuingOperations | -86.46M | 139.56M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for MDRX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|